Developing new vaccines and biologics for infectious diseases
Official title: Vaccine Manufacturing and Characterization Services
Funded at Advanced Bioscience Laboratories, INC. · NIH-9746951 · Data updated 2026-11-12
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2018 |
| Award (this year) | $69,356 |
| NIH project number | 272201800009I-0-27200001-1 |
| Project ID | NIH-9746951 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for emerging infectious diseases or those affected by drug-resistant pathogens.
✕Less likely to help
Patients with established vaccines for their conditions or those not at risk for infectious diseases may not receive benefit from this research.
What this research studies
This research focuses on the manufacturing and characterization of vaccines and biologics aimed at combating infectious diseases, including those caused by drug-resistant pathogens and potential bioterrorism agents. It involves a comprehensive approach that includes product development planning, optimization, and compliance with regulatory standards for clinical studies. Patients may benefit from the development of new vaccines that could provide protection against emerging and re-emerging infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to the introduction of new vaccines that enhance protection against serious infectious diseases.
How similar studies have gone: Previous research has shown success in developing vaccines through similar manufacturing and characterization approaches, indicating a promising avenue for future advancements.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Fouts, Timothy — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Timothy
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
-
Developing a vaccine to fight Candida auris infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from a serious fungal infection called Candida auris, with hopes of making it safe and effective for future testing.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.